Inhibition of adrenaline-induced fibrinolysis by alpha-adrenergic blocking agents in the rat.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D008738:Methyl Ethers / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013917:Thrombin / Q000494:pharmacology; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D004983:Ethanolamines; D005343:Fibrinolytic Agents; D007546:Isoquinolines; D008738:Methyl Ethers; D012702:Serotonin Antagonists; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D010656:Phenylephrine; D012701:Serotonin; D003983:Dibenzylchlorethamine; D011433:Propranolol; D013917:Thrombin; D007545:Isoproterenol; D011217:Practolol; D004837:Epinephrine; D010646:Phentolamine